These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 39095583)
1. Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Hoffmann H; Wartenberg M; Vorlova S; Karl-Schöller F; Kallius M; Reinhardt O; Öztürk A; Schuhmair LS; Burkhardt V; Gätzner S; Scheld D; Nandigama R; Zernecke A; Herterich S; Ergün S; Rosenwald A; Henke E Oncogene; 2024 Aug; 43(35):2661-2676. PubMed ID: 39095583 [TBL] [Abstract][Full Text] [Related]
2. Novel role of Snail 1 in promoting tumor neoangiogenesis. Zhang YK; Wang H; Guo YW; Yue Y Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975732 [TBL] [Abstract][Full Text] [Related]
3. SNAI1, an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization. Sun JX; Chang TF; Li MH; Sun LJ; Yan XC; Yang ZY; Liu Y; Xu WQ; Lv Y; Su JB; Liang L; Han H; Dou GR; Wang YS Angiogenesis; 2018 Aug; 21(3):635-652. PubMed ID: 29675549 [TBL] [Abstract][Full Text] [Related]
4. Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy. Cheng L; Liu W; Zhong C; Ni P; Ni S; Wang Q; Zhang Q; Zhang J; Liu J; Xu M; Yao X; Cen X; Wang G; Jiang C; Zhou F J Ethnopharmacol; 2021 Apr; 270():113770. PubMed ID: 33388426 [TBL] [Abstract][Full Text] [Related]
5. Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. Hultgren NW; Fang JS; Ziegler ME; Ramirez RN; Phan DTT; Hatch MMS; Welch-Reardon KM; Paniagua AE; Kim LS; Shon NN; Williams DS; Mortazavi A; Hughes CCW Nat Commun; 2020 Oct; 11(1):5400. PubMed ID: 33106502 [TBL] [Abstract][Full Text] [Related]
6. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition. Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225 [TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer. Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938 [TBL] [Abstract][Full Text] [Related]
8. Vascular Detransformation for Cancer Therapy. Fan Y Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902 [TBL] [Abstract][Full Text] [Related]
9. STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation. Qiu Z; Dong B; Guo W; Piotr R; Longmore G; Yang X; Yu Z; Deng J; Evers BM; Wu Y Theranostics; 2021; 11(16):7658-7670. PubMed ID: 34335956 [TBL] [Abstract][Full Text] [Related]
10. CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth. Chung TW; Kim SJ; Choi HJ; Kwak CH; Song KH; Suh SJ; Kim KJ; Ha KT; Park YG; Chang YC; Chang HW; Lee YC; Kim CH J Mol Med (Berl); 2013 Feb; 91(2):271-82. PubMed ID: 22935775 [TBL] [Abstract][Full Text] [Related]
11. Tie-1: A potential target for anti-angiogenesis therapy. Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611 [TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Sun B; Zhang D; Zhao N; Zhao X Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014 [TBL] [Abstract][Full Text] [Related]
13. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation. Jung HY; Fattet L; Tsai JH; Kajimoto T; Chang Q; Newton AC; Yang J Nat Cell Biol; 2019 Mar; 21(3):359-371. PubMed ID: 30804505 [TBL] [Abstract][Full Text] [Related]
15. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis. Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445 [TBL] [Abstract][Full Text] [Related]
16. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Wroblewski M; Bauer R; Cubas Córdova M; Udonta F; Ben-Batalla I; Legler K; Hauser C; Egberts J; Janning M; Velthaus J; Schulze C; Pantel K; Bokemeyer C; Loges S Nat Commun; 2017 Aug; 8(1):269. PubMed ID: 28814715 [TBL] [Abstract][Full Text] [Related]
17. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer. Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877 [TBL] [Abstract][Full Text] [Related]
18. Vessel pruning or healing: endothelial metabolism as a novel target? Cantelmo AR; Pircher A; Kalucka J; Carmeliet P Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641 [TBL] [Abstract][Full Text] [Related]
19. KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1. Qu X; Xu C; Yang W; Li Q; Tu S; Gao C Cancer Biomark; 2024; 39(3):231-243. PubMed ID: 38217587 [TBL] [Abstract][Full Text] [Related]
20. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression. Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]